Cognition Therapeutics, Inc. (CGTX) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts CGTX Hot Sheet
Join SI Premium – FREE
Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q2 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Macy's (M) Stock: Street Underestimates Earnings Pressure From Share Loss, Says Analyst
- S&P 500 above 8,000 in 2026 now looks ambitious, Citi says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
